85095-100 NDC - THINNR PROTOCOL (ADEPS SUILLUS, ADRENALINIUM, ADRENOCORTICOTROPHIN, AGRIMONIA EUPATORIA FLOS, AMMOUNIUM BROMATUM, ANACARDIUM ORIENTALE, ANTIMONIUM CRUDUM, CASTANEA SATIVA FLOS, CALCAREA CARBONICA, COENZYME A, CORTISONE ACETICUM, FUCUS VESICULOSUS, HYPOTHALAMUS, KALI BICHROMICUM, PITUITARUM POSTERIUM, RNA, SABADILLA, STAPHYSAGRIA, THYROIDINUM)

Drug Information

  • Product NDC: 85095-100
  • Proprietary Name: Thinnr PROTOCOL
  • Non Proprietary Name: Adeps suillus, Adrenalinium, Adrenocorticotrophin, Agrimonia eupatoria flos, Ammounium bromatum, Anacardium orientale, Antimonium crudum, Castanea sativa flos, Calcarea carbonica, Coenzyme A, Cortisone aceticum, Fucus vesiculosus, Hypothalamus, Kali bichromicum, Pituitarum posterium, RNA, Sabadilla, Staphysagria, Thyroidinum
  • Active Ingredient(s): 8 [hp_X]/mL ADEPS SUILLUS; 8 [hp_X]/mL AGRIMONIA EUPATORIA FLOWER; 8 [hp_X]/mL AMMONIUM BROMIDE; 8 [hp_X]/mL ANTIMONY TRISULFIDE; 8 [hp_X]/mL BOS TAURUS HYPOTHALAMUS; 8 [hp_X]/mL CASTANEA SATIVA FLOWER; 8 [hp_X]/mL COENZYME A; 8 [hp_X]/mL CORTICOTROPIN; 8 [hp_X]/mL CORTISONE ACETATE; 8 [hp_X]/mL DELPHINIUM STAPHISAGRIA SEED; 8 [hp_X]/mL EPINEPHRINE; 8 [hp_X]/mL FUCUS VESICULOSUS; 8 [hp_X]/mL OYSTER SHELL CALCIUM CARBONATE, CRUDE; 8 [hp_X]/mL POTASSIUM DICHROMATE; 8 [hp_X]/mL SACCHAROMYCES CEREVISIAE RNA; 8 [hp_X]/mL SCHOENOCAULON OFFICINALE SEED; 8 [hp_X]/mL SEMECARPUS ANACARDIUM JUICE; 8 [hp_X]/mL SUS SCROFA PITUITARY GLAND, POSTERIOR; 8 [hp_X]/mL THYROID, UNSPECIFIED
  • Administration Route(s): ORAL
  • Dosage Form(s): LIQUID
  • Pharmacy Class(es): Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Catecholamine [EPC]; Catecholamines [CS]; Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]; alpha-Adrenergic Agonist [EPC]; beta-Adrenergic Agonist [EPC]

Labeler Information

Field Name Field Value
Labeler Name: SLIMCELL, LLC
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:1/16/2025

Package Information

No. Package Code Package Description Billing Unit
185095-100-04118 mL in 1 BOTTLE (85095-100-04)

NDC Record

Field Name Field Value Definition
PRODUCT NDC85095-100The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEThinnr PROTOCOLThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEAdeps suillus, Adrenalinium, Adrenocorticotrophin, Agrimonia eupatoria flos, Ammounium bromatum, Anacardium orientale, Antimonium crudum, Castanea sativa flos, Calcarea carbonica, Coenzyme A, Cortisone aceticum, Fucus vesiculosus, Hypothalamus, Kali bichromicum, Pituitarum posterium, RNA, Sabadilla, Staphysagria, ThyroidinumThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMELIQUIDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE1/16/2025This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMESLIMCELL, LLCName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEADEPS SUILLUS; AGRIMONIA EUPATORIA FLOWER; AMMONIUM BROMIDE; ANTIMONY TRISULFIDE; BOS TAURUS HYPOTHALAMUS; CASTANEA SATIVA FLOWER; COENZYME A; CORTICOTROPIN; CORTISONE ACETATE; DELPHINIUM STAPHISAGRIA SEED; EPINEPHRINE; FUCUS VESICULOSUS; OYSTER SHELL CALCIUM CARBONATE, CRUDE; POTASSIUM DICHROMATE; SACCHAROMYCES CEREVISIAE RNA; SCHOENOCAULON OFFICINALE SEED; SEMECARPUS ANACARDIUM JUICE; SUS SCROFA PITUITARY GLAND, POSTERIOR; THYROID, UNSPECIFIEDAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8; 8 
ACTIVE INGRED UNIT[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL 
PHARM CLASSESAdrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Catecholamine [EPC], Catecholamines [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC] 

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 12/19/2025

Previous Code
Next Code